Afroway Pharma — Artesunate Exporter Profile
Indian Pharmaceutical Exporter · #2 for Artesunate · $15.9M export value · DGFT Verified
Afroway Pharma is the #2 Indian exporter of Artesunate with $15.9M in export value and 336 verified shipments. Afroway Pharma holds a 9.2% market share in Artesunate exports across 3 countries. The company exports 4 pharmaceutical products worth $27.0M across 3 therapeutic categories.
Afroway Pharma — Artesunate Export Profile: Buyers & Destinations
Where Does Afroway Pharma Export Artesunate?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $3.9M | 315 | 96.9% |
| SIERRA LEONA | $93.4K | 15 | 2.3% |
| SOMALIA | $30.7K | 6 | 0.8% |
Afroway Pharma exports Artesunate to 3 countries. The largest destination is KENYA accounting for 96.9% of Afroway Pharma's Artesunate shipments, followed by SIERRA LEONA (2.3%) and SOMALIA (0.8%). These destinations reflect Afroway Pharma's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Artesunate from Afroway Pharma?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| THE MANAGER | KENYA | $1.7M | 154 |
| THE MANAGER, | KENYA | $1.5M | 105 |
| EURO PHARMA LTD. | KENYA | $465.5K | 43 |
| MARENG INVESTMENTS CO. LTD., | KENYA | $119.5K | 9 |
| MARENG PHARMACEUTICAL LTD. | KENYA | $70.6K | 4 |
| EURO PHARMA LIMITED | KENYA | $56.2K | 3 |
| ADERDE PHARMACUTICALS | KENYA | $30.6K | 3 |
| ADERDE PHARMACUTICALS CUSTOM MARKET | KENYA | $28.8K | 3 |
| THE MANAGER DABIIB PHARMACEUTICAL MAIN JAIL ROAD OPPOSITE | SOMALIA | $24.4K | 4 |
| MARENG INVESTMENTS CO LTD | KENYA | $17.1K | 6 |
Afroway Pharma supplies Artesunate to 11 buyers globally. The largest buyer is THE MANAGER (KENYA), followed by THE MANAGER, (KENYA) and EURO PHARMA LTD. (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Artesunate Export Value and How Much Does Afroway Pharma Contribute?
India exported $71.2M worth of Artesunate through 6,110 shipments from 441 suppliers to 102 countries, serving 1,052 buyers globally. Afroway Pharma contributes $15.9M to this total, accounting for 9.2% of India's Artesunate exports. Afroway Pharma ships Artesunate to 3 countries through 11 buyers.
What Is the Average Shipment Value for Afroway Pharma's Artesunate Exports?
Afroway Pharma's average Artesunate shipment value is $47.2K per consignment, based on 336 shipments totaling $15.9M. The largest destination is KENYA (96.9% of Afroway Pharma's Artesunate exports).
How Does Afroway Pharma Compare to Other Indian Artesunate Exporters?
Afroway Pharma ranks #2 among 441 Indian Artesunate exporters with a 9.2% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($21.1M), AFROWAY PHARMA ($15.9M), LINCOLN PHARMACEUTICALS LTD ($7.6M). Afroway Pharma processed 336 shipments to 3 destination countries.
What Artesunate Formulations Does Afroway Pharma Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FLONART 120 ARTESUNATE INJECTION BATCH N | $304.7K | 13 |
| FLONART 120MG ARTESUNATE INJECTION BATCH | $245.3K | 11 |
| FLONART 180 MG ARTESUNATE FOR INJECTION | $161.8K | 7 |
| FLONART 120 MG ARTESUNATE FOR INJECTION | $161.0K | 7 |
| FLONART 60 MG ARTESUNATE FOR INJECTION 6 | $111.9K | 7 |
| FLONART 180 MG injection ARTESUNATE FOR | $111.7K | 3 |
| FLONART 120 MG ARTESUNATE INJECTION BATC | $104.4K | 7 |
| FLONART 120MGARTESUNATE INJECTIONBATCH | $102.8K | 6 |
| FLONART 120MG,ARTESUNATE INJECTION,BATCH | $94.6K | 3 |
| FLONART 60MG ARTESUNATE INJECTION BATCH | $70.3K | 6 |
Afroway Pharma exports 219 distinct Artesunate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLONART 120 ARTESUNATE INJECTION BATCH N with 13 shipments worth $304.7K.
How Does Afroway Pharma Compare to Nearest Artesunate Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED | $21.1M | 422 | 51 | $50.0K |
| 2 | AFROWAY PHARMA ★ | $15.9M | 336 | 3 | $47.2K |
| 5 | LINCOLN PHARMACEUTICALS LTD | $7.6M | 155 | 8 | $49.3K |
| 3 | MACLEODS PHARMACEUTICALS LTD | $4.8M | 95 | 26 | $50.0K |
Afroway Pharma ranks #2 among 441 Indian Artesunate exporters. Average shipment value of $47.2K compared to the market average of $161.4K. The closest competitors by value are IPCA LABORATORIES LIMITED and LINCOLN PHARMACEUTICALS LTD.
Which Indian Ports Ship Artesunate Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 902 | 14.8% |
| JNPT | 533 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 515 | 8.4% |
| AHEMDABAD ICD (INSBI6) | 423 | 6.9% |
| AHEMDABAD ICD | 419 | 6.9% |
| SAHAR AIR | 396 | 6.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 354 | 5.8% |
| NHAVA SHEVA SEA | 172 | 2.8% |
What Other Antimalarial & Antiparasitic Products Does Afroway Pharma Export?
Afroway Pharma also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Afroway Pharma's Artesunate Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Afroway Pharma. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times (pharmaceuticalcommerce.com). These disruptions can affect the timely delivery of pharmaceuticals, particularly to markets in West Asia and North Africa, regions that accounted for $1.75 billion of India's pharma exports in FY25.
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to expand their footprint in the US market, which remains the largest destination for Indian pharma exports, accounting for 34% of the total (economictimes.indiatimes.com). Afroway Pharma can leverage this opportunity by enhancing its compliance with US regulatory standards and strengthening its supply chain resilience.
The recent India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries (en.wikipedia.org). This agreement could facilitate easier access for Afroway Pharma's products into European markets, provided the company aligns with the stringent regulatory requirements of these regions.
Afroway Pharma — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India's pharmaceutical sector maintains high compliance standards, with numerous US FDA-approved facilities and WHO-GMP-approved plants (manufacturing.economictimes.indiatimes.com). Afroway Pharma's adherence to these standards is crucial for maintaining and expanding its export markets.
The evolving regulatory landscape, including the EU's falsified medicines directive, necessitates continuous quality assurance and compliance efforts. For Afroway Pharma, staying abreast of these changes and implementing necessary quality control measures will be essential to sustain its export growth and market credibility.
About Afroway Pharma
Afroway Pharma exports 4 products worth $27.0M. Beyond Artesunate, top products include Artemether, Kit, Lansoprazole. View the complete Afroway Pharma profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Artesunate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Artesunate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Afroway Pharma matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 336 individual customs records matching Afroway Pharma exporting Artesunate, covering 219 formulations to 3 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 102+ countries, 1,052+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Artesunate Export Data from Afroway Pharma
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Afroway Pharma's Artesunate exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Afroway Pharma
Full Company Profile →
4 products · $27.0M total trade · 3 categories
Artesunate Stats
Company Overview
Top Products by Afroway Pharma
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Afroway Pharma.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Artesunate. For current shipment-level data, contact TransData Nexus.